Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A randomised crossover trial to assess the acceptability and feasibility of electronic and paper based data collection of a patient reported outcome measure questionnaire for use in a clinical trial.


The aim of this study is to examine the acceptability and feasibility of an electronic and paper based case report form (questionnaire) developed for use in a future clinical trial (ACL SNNAP) of the management of patients following anterior cruciate ligament (ACL) injury.

We are carrying out this study because we want to ensure that the way we administer the questionnaire (electronic or paper) in this trial will be acceptable to patients with ACL injury. We feel that the thoughts and views of patients who have experienced an ACL injury are a vital part of this evaluation.


The study is a randomised within subjects crossover trial in which all participants will complete both paper and Web-based version of the same questionnaire. In this study, randomisation is of the order in which the participant will receive the questionnaire i.e either paper of electronic.

Anyone who has experienced an ACL injury at any point can participate.130 participants will be recruited from from either the physiotherapy/orthopaedic outpatient departments at Oxford University Hospitals NHS Foundation Trust or through postings on social media sites.


How can patients take part?

  • Patients can consent to participate in this study by completing the contact details form following the link below (alternatively they can contact the Oxford office, details below, and a paper verion of the form can be sent to the patient).
  • On receipt of this form the patient will then be asked to complete the questionnaire in two different formats (with a short time period in between), one will be e-mailed and the other sent in the post with a free post envelope to return the completed questionnaire.
  • This will be coordinated by the central study office in Oxford.
  • In addition, the patient will be asked to complete a short evaluation form to provide some feedback on the questionnaires.

Further information can be found in the Participant Information Sheet (link).  To participate in the study, please click on this link below to complete the Contact Details Form:

Take part

Our team